How many institutions held PYXS - Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share in Q4 2022?

31 institutional investors reported PYXS - Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share for Q4 2022. Use the holders table for investor-level position and value details.

Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (PYXS)

Q: What does CUSIP 747324101 represent in this 13F holders report?

CUSIP 747324101 is the security identifier for PYXS - Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

CUSIP: 747324101

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 62,130,557
Total 13F shares: 19,762,209
Share change: +269,750
Total reported value: $26,479,807
Price per share: $1.34
Number of holders: 31
Value change: -$1,331,635
Number of buys: 14
Number of sells: 13

Quarterly Holders Quick Answers

What is CUSIP 747324101?
CUSIP 747324101 identifies PYXS - Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2023
Previous quarter: Q3 2022

Recent filing periods for CUSIP 747324101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of PYXS - Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Laurion Capital Management LP	13F	Company	5.1%	3,170,803	$6,247,000	—	30 Sep 2022	13F
BVF INC/IL	13F	Company	4.7%	2,938,851	$5,790,000	—	30 Sep 2022	13F
BARCLAYS PLC	3/4/5 13F	10%+ Owner · Company	1.5% from 13F	3,477,975	$4,869,165	—	26 Apr 2022	3/4/5 13F
Bayer World Investments B.V.	3/4/5	Former 10% Owner	— class O/S missing	2,742,338	$3,839,273	—	13 Oct 2021	3/4/5
CITADEL ADVISORS LLC	13F	Company	2.5%	1,530,785	$3,015,000	—	30 Sep 2022	13F
PERCEPTIVE ADVISORS LLC	13F	Company	2.5%	1,528,812	$3,012,000	—	30 Sep 2022	13F
TANG CAPITAL MANAGEMENT LLC	13F	Company	2.3%	1,411,569	$2,781,000	—	30 Sep 2022	13F
VANGUARD GROUP INC	13F	Company	1.5%	917,384	$1,807,000	—	30 Sep 2022	13F
ORBIMED ADVISORS LLC	13F	Company	1.4%	848,252	$1,671,000	—	30 Sep 2022	13F
Newtyn Management, LLC	13F	Company	1.3%	800,000	$1,576,000	—	30 Sep 2022	13F
Cormorant Asset Management, LP	3/4/5 13F	Former 10% Owner · Company	1.1% from 13F	1,118,854	$1,566,396	—	13 Oct 2021	3/4/5 13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	1.2%	764,653	$1,506,000	—	30 Sep 2022	13F
HHLR ADVISORS, LTD.	13F	Company	1.2%	764,406	$1,506,000	—	30 Sep 2022	13F
Tekla Capital Management LLC	13F	Company	1.1%	708,303	$1,395,000	—	30 Sep 2022	13F
ACUTA CAPITAL PARTNERS, LLC	13F	Company	1.1%	669,158	$1,318,000	—	30 Sep 2022	13F
CITIGROUP INC	13F	Company	0.5%	312,308	$615,000	—	30 Sep 2022	13F
Logos Global Management LP	13F	Company	0.35%	220,434	$434,000	—	30 Sep 2022	13F
BlackRock Finance, Inc.	13F	Company	0.33%	206,554	$406,000	—	30 Sep 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.3%	188,821	$371,000	—	30 Sep 2022	13F
CREDIT SUISSE AG/	13F	Company	0.24%	152,018	$299,000	—	30 Sep 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.21%	128,802	$254,000	—	30 Sep 2022	13F
MORGAN STANLEY	13F	Company	0.2%	121,803	$240,000	—	30 Sep 2022	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.19%	120,295	$237,000	—	30 Sep 2022	13F
Ronald Herbst	3/4/5	Chief Scientific Officer	— mixed-class rows	118,674 mixed-class rows	$234,796	—	07 Oct 2021	3/4/5
MILLENNIUM MANAGEMENT LLC	13F	Company	0.14%	89,838	$177,000	—	30 Sep 2022	13F
Ritu Shah	3/4/5	Chief Operating Officer	— class O/S missing	31,344	$120,048	—	07 Oct 2021	3/4/5
TWO SIGMA INVESTMENTS, LP	13F	Company	0.06%	37,677	$74,000	—	30 Sep 2022	13F
STATE STREET CORP	13F	Company	0.05%	30,989	$61,000	—	30 Sep 2022	13F
NORTHERN TRUST CORP	13F	Company	0.04%	26,398	$52,000	—	30 Sep 2022	13F
DEUTSCHE BANK AG\	13F	Company	0.04%	25,000	$49,000	—	30 Sep 2022	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.04%	23,843	$46,000	—	30 Sep 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.03%	20,060	$40,000	—	30 Sep 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.03%	17,739	$35,000	—	30 Sep 2022	13F
Tower Research Capital LLC (TRC)	13F	Company	0.03%	15,736	$31,000	—	30 Sep 2022	13F
TUDOR INVESTMENT CORP ET AL	13F	Company	0.02%	13,624	$27,000	—	30 Sep 2022	13F
PRELUDE CAPITAL MANAGEMENT, LLC	13F	Company	0.02%	11,052	$22,000	—	30 Sep 2022	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.02%	10,400	$20,000	—	30 Sep 2022	13F
FMR LLC	13F	Company	0%	855	$2,000	—	30 Sep 2022	13F

Institutional Holders of Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (PYXS) as of Q4 2022

As of 31 Dec 2022, Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (PYXS) was held by 31 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 19,762,209 shares. The largest 10 holders included TANG CAPITAL MANAGEMENT LLC, Laurion Capital Management LP, BVF INC/IL, CITADEL ADVISORS LLC, Newtyn Management, LLC, BARCLAYS PLC, VANGUARD GROUP INC, ORBIMED ADVISORS LLC, HHLR ADVISORS, LTD., and Tekla Capital Management LLC. This page lists 31 institutional shareholders reporting positions in this security for the Q4 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders

Q4 2022 holders

Holder diff

-4

Investor	Q3 2022 Shares	Q4 2022 Shares	Share Diff	Share Chg %	Q3 2022 Value $	Q4 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.